India to South Africa: Gemcitabine Export Trade Route

The India to South Africa Gemcitabine corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $1.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's gemcitabine manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $23.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with gemcitabine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 18.7%, placing it at rank #9 among India's top gemcitabine export destinations globally.

On the import side, key buyers of Indian gemcitabine in South Africa include FRESENIUS KABI SOUTH AFRICA PTY, ACCORD HEALTHCARE C/O QESTMED, TO THE ORDER . and 16 others. FRESENIUS KABI SOUTH AFRICA PTY is the single largest importer with 1 shipments valued at $283.8K USD.

India's gemcitabine exports to South Africa are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 20 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 86% of total trade value on this route. The average shipment value of $23.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs & medi accord -gemcitabine and phar.drugs and med: cytigem 200 each vial contains: gemcitabine hydrochloride eq.to 200mg gemcitabine free base, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI SOUTH AFRICA PTY is the largest importer with 1 shipments worth $283.8K USD — representing 26% of all gemcitabine imports from India on this route. A total of 19 buyers are active on this corridor.